United States· US:57664-851_330a0641-aaa9-e9c1-e063-6294a90ada9e
Minocycline Hydrochloride
A minocycline product containing minocycline hydrochloride, registered in United States by Sun Pharmaceutical Industries, Inc.. The same ATC class is registered in 5 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Minocycline is registered in 5 of 19 countries.
Countries holding a registration under ATC A01AB23 (minocycline), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Minocycline · ATC A01AB23
5 / 19 countries
- Canada
- Finlandprice
- Italyprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of minocycline costs, country by country.
Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.
- United States: $0.0036 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Minocycline · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- US United States$0.0036 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Minocycline Hydrochloride
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Country
- United States (US)
- ATC code
- A01AB23
- ATC class
- Minocycline
- Defined daily dose
- 1 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 2
- ndc115766485113500 CAPSULE in 1 BOTTLE (57664-851-13)
- ndc115766485188100 CAPSULE in 1 BOTTLE (57664-851-88)
Regulatory notes
Interactions
4 interactions on record for minocycline.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Minocycline · interactions on record
4 records
- 1 severe
- 3 moderate
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Porfimer sodiumL01XD01moderate
- MethoxsalenL01XD10moderate
- VerteporfinS01LA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Minocycline in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumMinocycline EG 50 mgEG
- CanadaMINOCYCLINEAA PHARMA INC
- United KingdomAknemin 50 capsulesAlmirall Ltd
- NorwayMinocinTeofarma
- NetherlandsMinocycline Aurobindo 100 mg, omhulde tablettenAurobindo Pharma B.V.
- GermanyMinoplusChephasaar Chemisch-Pharmazeutische Fabrik Gmbh
- IrelandMinocin SA 100 mg Modified Release CapsulesViatris Healthcare Limited
- FranceMYNOCINE 100 mg, géluleLABORATOIRE XO
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Minostad
- Belgium · Klinotab, Mino-50
- Bulgaria · Миноциклин Екофарм
- Cyprus · Minaxen
- Germany · Minoplus, Skid
- Spain · Minocin Vía Oral
- France · Kyno, Mynocine
- United Kingdom (Northern Ireland) · Dentomycin, Minocin Mr
- Greece · Minocin
- Ireland · Minocin Sa, Minosil
- Italy · Minocin
- Luxembourg · Klinotab, Mino
- Malta · Minaxen
- Netherlands · Minocycline Eurogenerics, Minocycline Hydrochloride Dihydrate Aurobindo
- Portugal · Cipancin, Minocin
- Romania · Minoz Ep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec2336f4-e2ad-4c67-b1e8-2386f070d102 GET /v1/drugs/ec2336f4-e2ad-4c67-b1e8-2386f070d102?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "0020414E5U",
"rxcui": "6979",
"inchikey": "GLMUAFMGXXHGLU-VQAITOIOSA-N",
"display_name": "MINOCYCLINE HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 1
},
"spl_meta": {
"7e2390b7-242c-43ff-afb3-b0a5e79351d3": {
"match": "brand_token",
"title": "MINOCYCLINE HYDROCHLORIDE CAPSULE [PD-RX PHARMACEUTICALS, INC.]",
"spl_version": "27",
"published_date": "2026-05-15"
}
},
"productid": "57664-851_330a0641-aaa9-e9c1-e063-6294a90ada9e",
"productndc": "57664-851",
"dosage_form": "CAPSULE",
"orange_book": {
"appl_no": "090867",
"products": [
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 50MG BASE",
"product_no": "001",
"approval_date": "May 13, 2013"
},
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 75MG BASE",
"product_no": "002",
"approval_date": "May 13, 2013"
},
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 100MG BASE",
"product_no": "003",
"approval_date": "May 13, 2013"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "MINOCYCLINE HYDROCHLORIDE",
"proprietary_name": "Minocycline Hydrochloride",
"active_ingred_unit": "mg/1",
"application_number": "ANDA090867",
"marketing_category": "ANDA",
"nonproprietary_name": "Minocycline Hydrochloride",
"start_marketing_date": "20130513",
"active_numerator_strength": "50"
}See everything about minocycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.